Cargando…
Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
According to the WHO’s recently released worldwide cancer data for 2020, liver cancer ranks sixth in morbidity and third in mortality among all malignancies. Hepatocellular carcinoma (HCC), the most common kind of liver cancer, accounts approximately for 80% of all primary liver malignancies and is...
Autores principales: | Kotsari, Maria, Dimopoulou, Vassiliki, Koskinas, John, Armakolas, Athanasios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380581/ https://www.ncbi.nlm.nih.gov/pubmed/37511228 http://dx.doi.org/10.3390/ijms241411471 |
Ejemplares similares
-
Liquid Biopsies, Novel Approaches and Future Directions
por: Armakolas, Athanasios, et al.
Publicado: (2023) -
Ariadne’s Thread in the Network of Hepatocellular Carcinoma Immunobiology
por: Koskinas, John, et al.
Publicado: (2021) -
Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011) -
Emerging Therapies for Hepatocellular Carcinoma (HCC)
por: Chakraborty, Eesha, et al.
Publicado: (2022) -
Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)
por: Bicer, Fuat, et al.
Publicado: (2023)